Doctor profile · Federal record

Dr. Seung-Yil Song, M.D.

Medical Oncology Physician (CMS: Medical Oncology) · San Diego, CA

  • NPI 1578677860
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 60 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
7930 Frost St Ste 405
San Diego, CA 921232759
(858) 571-2811
fax (858) 571-2814

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
August 5, 2025
Year of graduation
1966 — 60 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
California #A25278
Medicaid
CA #00A252780

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1578677860. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
52,756
Distinct HCPCS
10
Medicare allowed
$658,868
HCPCS Description Services Patients Avg allowed
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram 28,200 12 $0
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 6,400 44 $8
J1626 Injection, granisetron hydrochloride, 100 mcg 2,746 39 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 2,006 207 $8
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 1,741 18 $8
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,677 40 $0
82950 Blood glucose (sugar) level after receiving dose of glucose 1,147 181 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 1,034 172 $98
99214 Established patient office or other outpatient visit, 30-39 minutes 932 183 $139
36415 Insertion of needle into vein for collection of blood sample 793 189 $8

In context: peer comparison

Among 3 peers in this city , average services per provider: 885. This provider delivers 60× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,979
Transactions
102
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 12 $999.96
SOBI, INC 6 $326.48
PFIZER INC. 14 $302.07
E.R. Squibb & Sons, L.L.C. 14 $238.05
AstraZeneca Pharmaceuticals LP 10 $217.63
Alexion Pharmaceuticals, Inc. 7 $200.65
Celgene Corporation 10 $192.46
Eisai Inc. 6 $154.10
Merck Sharp & Dohme LLC 6 $152.14
Janssen Biotech, Inc. 5 $106.36
Amgen Inc. 1 $104.75
PUMA BIOTECHNOLOGY, INC. 3 $71.70
Lilly USA, LLC 3 $65.42
Rigel Pharmaceuticals, Inc. 2 $64.84
Gilead Sciences, Inc. 3 $63.29

By nature of payment

Food and Beverage
$2,780
Long term medical supply or device loan
$1,000
Education
$199

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,060
Patients
310
Total drug cost
$25,047
Drug Type Claims Patients Total cost
Losartan Potassium Generic 139 43 $2,974
Amlodipine Besylate Generic 118 39 $2,048
Carvedilol Generic 93 31 $1,662
Furosemide Generic 89 24 $745
Levothyroxine Sodium Generic 83 19 $1,335
Potassium Chloride Generic 71 15 $3,827
Famotidine Generic 64 24 $1,675
Atorvastatin Calcium Generic 63 17 $1,584
Raloxifene Hcl Generic 62 19 $4,036
Isosorbide Mononitrate Er (Isosorbide Mononitrate) Brand 56 23 $1,903

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Seung-Yil Song's medical specialty?
Dr. Seung-Yil Song practices Medical Oncology Physician in San Diego, CA.
Where does Dr. Seung-Yil Song practice?
Dr. Seung-Yil Song practices at 7930 Frost St Ste 405, San Diego, CA 921232759. Office phone: 8585712811.
What is Dr. Seung-Yil Song's NPI?
Dr. Seung-Yil Song's National Provider Identifier (NPI) is 1578677860, issued by NPPES.
Does Dr. Seung-Yil Song accept Medicare assignment?
Yes. Dr. Seung-Yil Song accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Seung-Yil Song commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS Q5106); Injection, granisetron hydrochloride, 100 mcg (HCPCS J1626). Source: CMS Medicare Physician & Other Practitioners file.